Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries The Gross Law Firm Announces Class Actions on Behalf of Shareholders of QFIN, ITRM and SLQT By: The Gross Law Firm via AccessWire August 19, 2021 at 14:50 PM EDT NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.360 DigiTech, Inc. (NASDAQ:QFIN)Investors Affected : April 29, 2021 - July 7, 2021A class action has commenced on behalf of certain shareholders in 360 DigiTech, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had been collecting personal information in violation of relevant People's Republic of China laws and regulations; (ii) accordingly, 360 DigiTech was exposed to an increased risk of regulatory scrutiny and/or enforcement action; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.Shareholders may find more information at https://securitiesclasslaw.com/securities/360-digitech-inc-loss-submission-form/?id=18728&from=1Iterum Therapeutics Plc (NASDAQ:ITRM)Investors Affected : November 30, 2020 - July 23, 2021A class action has commenced on behalf of certain shareholders in Iterum Therapeutics Plc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the sulopenem New Drug Application ("NDA") lacked sufficient data to support approval for the treatment of adult women with urinary tract infections caused by designated susceptible microorganisms proven or strongly suspected to be nonsusceptible to a quinolone; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the sulopenem NDA in its current form; (iii) Defendants downplayed the severity of issues and deficiencies associated with the sulopenem NDA; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.Shareholders may find more information at https://securitiesclasslaw.com/securities/iterum-therapeutics-plc-loss-submission-form/?id=18728&from=1Selectquote, Inc. (NYSE:SLQT)Investors Affected : February 8, 2021 - May 11, 2021A class action has commenced on behalf of certain shareholders in Selectquote, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Shareholders may find more information at https://securitiesclasslaw.com/securities/selectquote-inc-loss-submission-form/?id=18728&from=1The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.comPhone: (212) 537-9430Fax: (833) 862-7770SOURCE: The Gross Law Firm View source version on accesswire.com: https://www.accesswire.com/660595/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-QFIN-ITRM-and-SLQT Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of QFIN, ITRM and SLQT By: The Gross Law Firm via AccessWire August 19, 2021 at 14:50 PM EDT NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.360 DigiTech, Inc. (NASDAQ:QFIN)Investors Affected : April 29, 2021 - July 7, 2021A class action has commenced on behalf of certain shareholders in 360 DigiTech, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had been collecting personal information in violation of relevant People's Republic of China laws and regulations; (ii) accordingly, 360 DigiTech was exposed to an increased risk of regulatory scrutiny and/or enforcement action; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.Shareholders may find more information at https://securitiesclasslaw.com/securities/360-digitech-inc-loss-submission-form/?id=18728&from=1Iterum Therapeutics Plc (NASDAQ:ITRM)Investors Affected : November 30, 2020 - July 23, 2021A class action has commenced on behalf of certain shareholders in Iterum Therapeutics Plc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the sulopenem New Drug Application ("NDA") lacked sufficient data to support approval for the treatment of adult women with urinary tract infections caused by designated susceptible microorganisms proven or strongly suspected to be nonsusceptible to a quinolone; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the sulopenem NDA in its current form; (iii) Defendants downplayed the severity of issues and deficiencies associated with the sulopenem NDA; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.Shareholders may find more information at https://securitiesclasslaw.com/securities/iterum-therapeutics-plc-loss-submission-form/?id=18728&from=1Selectquote, Inc. (NYSE:SLQT)Investors Affected : February 8, 2021 - May 11, 2021A class action has commenced on behalf of certain shareholders in Selectquote, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Shareholders may find more information at https://securitiesclasslaw.com/securities/selectquote-inc-loss-submission-form/?id=18728&from=1The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.comPhone: (212) 537-9430Fax: (833) 862-7770SOURCE: The Gross Law Firm View source version on accesswire.com: https://www.accesswire.com/660595/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-QFIN-ITRM-and-SLQT